Kauffman Michael

Average Profitability
<0.0001%
Insider Buys Quantity
2
Insider Buys Sum
$84,559.40
Insider Sells Quantity
68
Insider Sells Sum
$33.36M

Insider Activity of Kauffman Michael

According to the SEC Form 4 filings, Kauffman Michael, being in a position of

  1. director at Adicet Bio, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 5900 shares for $8,437,
    over all time since 2024-06-05, has bought 0 shares, and sold 5900 shares for $8,437.

The largest purchase of all time was on 2014-09-17 and amounted to 6000 shares of Verastem, Inc. for $54,599.

The largest sale of all time was on 2014-07-02 and amounted to 400000 shares of Karyopharm Therapeutics Inc. for $17M.

Biography of Kauffman Michael

No biography is available at this moment.

2024-06-05SaleAdicet Bio, Inc.
ACET
director
5,900
0.0071%
$1.43$8,437-4.51%
2022-02-28SaleKaryopharm Therapeutics Inc.
KPTI
director
12,452
0.0159%
$10.24$127,477-51.02%
2022-02-17SaleKaryopharm Therapeutics Inc.
KPTI
director
18,167
0.0237%
$12.12$220,246-57.42%
2022-02-07SaleKaryopharm Therapeutics Inc.
KPTI
director
13,471
0.0167%
$9.86$132,851-49.61%
2022-01-03SaleKezar Life Sciences, Inc.
KZR
director
5,000
0.0086%
$16.45$82,250-38.58%
2021-03-18SaleKaryopharm Therapeutics Inc.
KPTI
Chief Executive Officer
4,000
0.0055%
$12.39$49,553-31.98%
2021-02-18SaleKaryopharm Therapeutics Inc.
KPTI
Chief Executive Officer
18,990
0.0255%
$14.83$281,644-42.84%
2021-02-11SaleKaryopharm Therapeutics Inc.
KPTI
Chief Executive Officer
13,243
0.018%
$15.52$205,518-45.02%
2020-10-12SaleKaryopharm Therapeutics Inc.
KPTI
Chief Executive Officer
7,500
0.01%
$14.89$111,683-31.24%
2020-08-17SaleKaryopharm Therapeutics Inc.
KPTI
Chief Executive Officer
1,477
0.002%
$15.00$22,155-6.72%
2020-07-15SaleKaryopharm Therapeutics Inc.
KPTI
Chief Executive Officer
7,500
0.0102%
$19.43$145,723-23.92%
2020-07-10SaleKaryopharm Therapeutics Inc.
KPTI
Chief Executive Officer
7,500
0.0101%
$19.01$142,539-22.85%
2020-07-09SaleKaryopharm Therapeutics Inc.
KPTI
Chief Executive Officer
7,500
0.0106%
$19.53$146,487-21.51%
2020-06-22SaleKaryopharm Therapeutics Inc.
KPTI
Chief Executive Officer
7,500
0.0108%
$20.00$150,000-21.38%
2020-06-15SaleKaryopharm Therapeutics Inc.
KPTI
Chief Executive Officer
7,500
0.0096%
$16.37$122,779-14.13%
2020-06-10SaleKaryopharm Therapeutics Inc.
KPTI
Chief Executive Officer
7,500
0.0106%
$18.13$135,944-14.19%
2020-06-09SaleKaryopharm Therapeutics Inc.
KPTI
Chief Executive Officer
7,500
0.0106%
$18.50$138,746-15.88%
2020-05-18SaleKaryopharm Therapeutics Inc.
KPTI
Chief Executive Officer
7,500
0.011%
$20.00$150,000-18.44%
2020-05-15SaleKaryopharm Therapeutics Inc.
KPTI
Chief Executive Officer
7,500
0.01%
$18.65$139,841-20.09%
2020-05-07SaleKaryopharm Therapeutics Inc.
KPTI
Chief Executive Officer
15,000
0.0207%
$19.63$294,414-21.53%
Company
About Prismo.proNewsPrivacy PolicyTerms of ServiceContact Us
Investing Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.